Microwave thermotherapy for benign prostatic hyperplasia

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  Hoffman, Richard M ^a   Monga, M ^b   Elliot, S P ^b   MacDonald, R ^b   Wilt, T J ^b  

^a NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

Adrenergic alpha antagonists therapeutic use ; Aged; Humans; Hyperthermia, induced *methods ; Microwaves *therapeutic use ; Prostatic hyperplasia *therapy ; Randomized controlled trials as topic; Transurethral resection of prostate

Indexed keywords

TERAZOSIN;

ASTHENIA; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE ASSOCIATION; DIZZINESS; DYSURIA; ESOPHAGUS STRICTURE; FLOW RATE; FOLLOW UP; HEALTH HAZARD; HEMATURIA; HUMAN; INTERMETHOD COMPARISON; MICROWAVE THERAPY; MICTURITION; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PROSTATE HYPERTROPHY; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; RETROGRADE EJACULATION; REVIEW; RISK FACTOR; SYMPTOM; TRANSURETHRAL ELECTROVAPORIZATION; TRANSURETHRAL RESECTION; URINARY TRACT INFECTION; URINE RETENTION;

EID: 38949092579     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004135.pub2     Document Type: Review

References (52)

1. Abbou 1995 {published data only} Abbou CC, Payan C, Viens-Bitker C, Richard F, Boccon-Gibod L, Jardin A, Beurton D, LeDucs A, Fermanian J, Thibault P, The French BPH Hyperthermia Group. Transrectal and transurethral hyperthermia versus sham treatment in benign prostatic hyperplasia: a double-blind randomized multicentre clinical trial. Br J Urol 1995;76:619-24.
2. Ahmed 1997 {published data only} Ahmed M, Bell T, Lawrence WT, Ward JP, Watson GM. Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study. Br J Urol 1997;79:181-5.
3. Bdesha 1994 {published data only} Bdesha AS, Bunce CJ, Snell ME, Witherow RO. A sham controlled trial of transurethral microwave therapy with subsequent treatment of the control group. J Urol 1994;152:453-8.
4. Blute 1996 {published data only} Blute ML, Patterson DE, Segura JW, Tomera KM, Hellerstein DK. Transurethral microwave thermotherapy v sham treatment: double-blind randomized study. J Endourol 1996;10:565-73.
5. D'Ancona 1998 {published data only} D'Ancona FC, Francisca EA, Witjes WP, Welling L, Debruyne FM, De La Rosette JJ. Transurethral resection of the prostate vs high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: long-term results. Br J Urol 1998;81:259-64.
6. Dahlstrand 1995 {published data only} Dahlstrand C, Walden M, Geirsson G, Pettersson S. Transurethral microwave thermotherapy versus transurethral resection for symptomatic benign prostatic obstruction: a prospective randomized study with a 2-year follow-up. Br J Urol 1995;76:614-8.
7. De Wildt 1996 {published data only} De Wildt MJ, Hubregtse M, Ogden C, Carter SS, Debruyne FM, De la Rosette JJ. A 12-month study of the placebo effect in transurethral microwave thermotherapy. Br J Urol 1996;77:221-7.
8. Djavan 1999 {published data only} Djavan B, Roehrborn CG, Shariat S, Ghawidel K, Marberger M. Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia. J Urol 1999;161:139- 43.
9. Floratos 2001 {published data only} Floratos DL, Kiemeney LA, Rossi C, Kortmann BB, Debruyne FM, de La Rosette JJ. Long-term followup of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study. J Urol 2001;165:1533-8.
10. Larson 1998 {published data only} Larson TR, Blute ML, Bruskewitz RC, Mayer RD, Ugarte RR, Utz WJ.A high-efficiency microwave thermoablation system for the treatment of benign prostatic hyperplasia: results of a randomized, sham-controlled, prospective, double-blind, multicenter clinical trial. Urology 1998;51:731-42.
11. Mattiasson 2007 {published data only} Mattiasson A, Wagrell L, Schelin S, et al.Five-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study. Urology 2007;69:91-6; discussion 96-7.
12. Nawrocki 1997 {published data only} Nawrocki JD, Bell TJ, Lawrence WT, Ward JP. A randomized controlled trial of transurethral microwave thermotherapy. Br J Urol 1997;79:389-93.
13. Norby 2002a {published data only} Norby B, Nielsen HV, Frimodt-Moller PC. Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia. BJU Int 2002;90:853-62.
14. Roehrborn 1998 {published data only} *Roehrborn CG, Preminger G, Newhall P, Denstedt J, Razvi H, Chin LJ, Perlmutter A, Barzell W, Whitmore W, Fritzsch R, Sanders J, Sech S, Womack S. Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: results of a randomized, double-blind, multicenter, sham-controlled trial. Urology 1998;51:19-28.
15. Wagrell 2002 {published data only} *Wagrell L, Schelin S, Nordling J, Richthoff J, Mangnusson B, Schain M, Larson T, Boyle E, Duelund J, Kroyer K, Ageheim H, Mattiasson A. Feedback microwave thermotherapy versus TURP for clinical BPH-a randomized controlled multicenter study. Urology 2002;60:292-9.
16. Albala 2000 Albala DM, Turk TM, Fulmer BR, Koleski F, Andriole G, Davis BE, Eure GR, Kabalin JN, Lingeman J, Nuzzarello J, Sundaram C. Periurethral transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia: an interim 1-year safety and efficacy analysis using the thermatrx TMx-2000. Tech Urol 2000;6:288-93.
17. Baert 1994 Baert L, Ameye F, Goethuys H, Petrovich Z. Microwave hyperthermia for the treatment of benign prostatic hyperplasia. Semin Urol 1994;12:174-80.
18. Bdesha 1993 Bdesha AS, Bunce CJ, Kelleher JP, Snell ME, Vukusic J, Witherow RO. Transurethral microwave treatment for benign prostatic hypertrophy: a randomised controlled clinical trial. BMJ 1993;306:1293-6.
19. Brehmer 1999 Brehmer M, Wiksell H, Kinn A. Sham treatment compared with 30 or 60 min of thermotherapy for benign prostatic hyperplasia: a randomized study. BJU Int 1999;84:292-6.
20. D'Ancona 1997 D'Ancona FC, Francisca EA, Witjes WP, Welling L, Debruyne FM, de la Rosette JJ. High energy thermotherapy versus transurethral resection in the treatment of benign prostatic hyperplasia: results of a prospective randomized study with 1 year of followup. J Urol 1997;158:120-5.
21. Dahlstrand 1993 Dahlstrand C, Geirsson G, Fall M, Pettersson S. Transurethral microwave thermotherapy versus transurethral resection for benign prostatic hyperplasia: preliminary results of a randomized study. Eur Urol 1993;23:292-8.
22. Dahlstrand 1994 Dahlstrand C, Walden M, Geirsson G, Sommar S, Pettersson S. Transurethral microwave thermotherapy versus transurethral resection for BPH. Transurethral microwave thermotherapy versus transurethral resection for BPH. Prog Clin Biol Res 1994;386:455-61.
23. de la Rosette 1994 De La Rosette JJMCH, De Wilt MJAM, Alivizatos G, Froeling FMJA, Debruyne FMJ. Transurethral microwave thermotherapy (TUMT) in benign prostatic hyperplasia: placebo versus TUMT. Urology 1994;44:58-63.
24. de la Rosette 2003 de La Rosette JJ, Floratos DL, Severens JL, Kiemeney LA, Debruyne FM, Pilar Laguna M. Transurethral resection vs microwave thermotherapy of the prostate: a cost-consequences analysis. BJU Int 2003;92:713-8.
25. Djavan 2001 Djavan B, Seitz C, Roehrborn CG, Remzi M, Fakhari M, Waldert M, Basharkhah A, Planz B, Harik M, Marberger M. Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months. Urology 2001;57:66-70.
26. Francisca 1997 Francisca EA, d'Ancona FC, Hendriks JC, Kiemeney LA, Debruyne FM, de la Rosette JJ. Quality of life assessment in patients treated with lower energy thermotherapy (Prostasoft 2.0): results of a randomized transurethral microwave thermotherapy versus sham study. J Urol 1997;158:1839-44.
27. Francisca 2000 Francisca EA, d'Ancona FC, Hendriks JC, Kiemeney LA, Debruyne FM, de La Rosette JJ. A randomized study comparing high-energy TUMT to TURP: quality-of-life results. Eur Urol 2000;38:569-75.
28. Kobelt 2004 Kobelt G, Spangberg A, Mattiasson A. The cost of feedback microwave thermotherapy compared with transurethral resection of the prostate for treating benign prostatic hyperplasia. BJU Int 2004;93:543-8.
29. Norby 2002b Norby B, Nielsen HV, Frimodt-Moller PC. Cost-effectiveness of new treatments for benign prostatic hyperplasia: results of a randomized trial comparing the short-term cost-effectiveness of transurethral interstitial laser coagulation of the prostate, transurethral microwave thermotherapy and standard transurethral resection or incision of the prostate. Scand J Urol Nephrol 2002;36:286-95.
30. Ogden 1993 Ogden CW, Reddy P, Johnson H, Ramsay JW, Carter SS. Sham-versus transurethral microwave thermotherapy in patients with symptoms of benign prostatic bladder outflow obstruction. Lancet 1993;341:14- 7.
31. Schelin 2006 Schelin S, Geertsen U, Walter S, et al.Feedback microwave thermotherapy versus TURP/prostate enucleation surgery in patients with benign prostatic hyperplasia and persistent urinary retention: a prospective, randomized, controlled, multicenter study. Urology 2006;68:795-9.
32. Tan 2005 Tan AH, Nott L, Hardie WR, Chin JL, Denstedt JD, Razvi H. Long-term results of microwave thermotherapy for symptomatic benign prostatic hyperplasia. J Endourol 2005;19:1191-5.
33. Trachtenberg 1998 Trachtenberg J, Roehborn CG. Updated results of a randomized, double-blind, multicenter sham-controlled trial of microwave thermotherapy with the Dornier Urowave in patients with symptomatic benign prostatic hyperplasia. World J Urol 1998;16:102-8.
34. Venn 1995 Venn SN, Montgomery BS, Sheppard SA, Hughes SW, Beard RC, Bultitiude MI, Lloyd-Davies RW, Tiptaft RC. Microwave hyperthermia in benign prostatic hypertrophy: a controlled clinical trial. Br J Urol 1995;76:73-6.
35. Wagrell 2004 Wagrell L, Schelin S, Nordling J, Richthoff J, Magnusson B, Schain M, Larson T, Boyle E, Duelund J, Kroyer K, Ageheim K, Mattiasson A. Three-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study. Urology 2004;64:698-702.
36. Walden 1998 Walden M, Acosta S, Carlsson P, Pettersson S, Dahlstrand C. A cost-effectiveness analysis of transurethral resection of the prostate and transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia: two-year follow-up. Scand J Urol Nephrol 1998;32:204-10.
37. Zerbib 1992 Zerbib M, Steg A, Conquy S, Martinache PR, Flam TA, Debre B. Localized hyperthermia versus the sham procedure in obstructive benign hyperplasia of the prostate: a prospective randomized study. J Urol 1992;147:1048-52.
38. Zerbib 1994 Zerbib M, Steg A, Conquy S, Debre B. Hyperthermia: a randomized prospective study applying hyperthermia or a sham procedure in obstructive benign hyperplasia of the prostate. Prog Clin Biol Res 1994;386:439-48.
39. AUA 2003 AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol 2003;170:530-547.
40. Barry 1990 Barry MJ. Medical outcomes research and benign prostatic hyperplasia. Prostate 1990;3 (Suppl):61-74.
41. Bolmsjo 1996 Bolmsjo M, Wagrell L, Hallin A, Eliasson T, Erlandsson BE, Matiasson A. The heat is on-but how? A comparison of TUMT devices. Br J Urol 1996;78:564-72.
42. Borboroglu 1999 Borboroglu PG, Kane CJ, Ward JF, Roberts JL, Sands JP. Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol 1999;162:1307-10.
43. Chapple 2001 Chapple CR. Lower urinary tract symptoms suggestive of benign prostatic obstruction-Triumph: design and implementation. Eur Urol 2001;39 (Suppl):31-6.
44. EAU 2002 de la Rosette J, Alivizatos G, Madersbacher S, Sanz CR, Nordling J, Emberton M. European Association of Urology Guidelines on benign prostatic hyperplasia. Eur Urol 2001;40:256-63.
45. FDA 2000 United States Food, Drug Administration. http://www.fda.gov/cdrh/safety/bph.html.
46. Jepsen 1998 Jepsen JV, Bruskewitz RC. Recent developments in the surgical management of benign prostatic hyperplasia. Urology 1998;51(Suppl 4A):23-31.
47. McConnell 1994 McConnell JD, Barry MJ, Bruskewitz RC, Bueschan AJ, Denton SE, Holtgrewe HL, et al.Benign Prostatic Hyperplasia: Diagnosis and Treatment. Clinical Practice Guidelines. Rockville, Maryland: U.S. Department of Health and Human Services. Public Health Service. Agency for Health Care Policy and Research: AHCPR Publication No. 94-0582, 1994.
48. Mebust 1989 Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243-7.
49. Roos 1998 Roos NP, Wennberg JE, Malenka DJ, Fisher ES, McPherson K, Andersen TF, et al.Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 1989;320:1120-4.
50. Walmsley 2004 Walmsley K, Kaplan SA.Transurethral microwave thermotherapy for benign prostate hyperplasia: separating truth from marketing hype. J Urol 2004;172:1249-55.
51. Wasson 1995 Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson WG. Comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med 1995;332:75-9.
52. Wei 2004 Wei JT, Calhoun EA, Jacobsen SJ. Chapter 2. Benign prostatic hyperplasia. Urologic Diseases in America, Litwin MS, Saigal CS, editors. Washington, DC: US Department of Health and Human Services, Public Health Service, National Institute of Diabetes and Digestive and Kidney Diseases: US Government Publishing Office; NIH Publication No. 04-55112, 2004:43-70.